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Erysipelas, caused by the bacterium Erysipelothrix rhusiopathiae, is re-emerging in
swine and poultry production systems worldwide. While the global genomic diversity of
this species has been characterized, how much of this genomic and functional diversity
is maintained at smaller scales is unclear. Specifically, while several key immunogenic
surface proteins have been identified for E. rhusiopathiae, little is known about their
presence among field strains and their divergence from vaccines, which could result in
vaccine failure. Here, a comparative genomics approach was taken to determine the
diversity of E. rhusiopathiae strains in pigs in Great Britain over nearly three decades, as
well as to assess the field strains’ divergence from the vaccine strain most commonly
used in British pigs. In addition, the presence/absence and variability of 13 previously
described immunogenic surface proteins was determined, including SpaA which is
considered a key immunogen. We found a high diversity of E. rhusiopathiae strains in
British pigs, similar to the situation described in European poultry but in contrast to swine
production systems in Asia. Of the four clades of E. rhusiopathiae found globally, three
were represented among British pig isolates, with Clade 2 being the most common. All
British pig isolates had one amino acid difference in the immunoprotective domain of
the SpaA protein compared to the vaccine strain. However, we were able to confirm
using in silico structural protein analyses that this difference is unlikely to compromise
vaccine protection. Of 12 other known immunogenic surface proteins of E. rhusiopathiae
examined, 11 were found to be present in all British pig isolates and the vaccine strain,
but with highly variable degrees of conservation at the amino acid sequence level,
ranging from 0.3 to 27% variant positions. Moreover, the phylogenetic incongruence
of these proteins suggests that horizontal transfer of genes encoding for antigens is
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commonplace for this bacterium. We hypothesize that the sequence variants in these
proteins could be responsible for differences in the efficacy of the immune response.
Our results provide the necessary basis for testing this hypothesis through in vitro and
in vivo studies.
Keywords: antigen, Erysipelothrix rhusiopathiae, genomics, Great Britain, pigs (Sus domesticus), vaccine, whole
genome sequencing
INTRODUCTION
Erysipelothrix rhusiopathiae, the causative agent of erysipelas,
remains a persistent challenge for swine and poultry production
systems worldwide. Although well-controlled for decades
through vaccination, erysipelas is re-emerging in several
European and Asian countries (Eriksson et al., 2013; Kwok et al.,
2014; Janßen et al., 2015; Ogawa et al., 2017). E. rhusiopathiae was
also recently implicated in large-scale mortalities and population
declines in muskoxen and other wild ungulates in North America
(Kutz et al., 2015; Forde T.L. et al., 2016). While Erysipelothrix
spp. infection can impact all pig production stages and is a
common and significant cause of carcass condemnation, its
true economic burden is largely unknown. The E. rhusiopathiae
genome is comprised of a single chromosome of about 1.8 million
base pairs (MB), with an average GC content of 36.5% (Ogawa
et al., 2011; Kwok et al., 2014; Tang et al., 2016). Comparative
genomic analysis of a diverse collection of E. rhusiopathiae
isolates from a wide range of host species recently led to a better
understanding of the global diversity and population structure
of this species (Forde T. et al., 2016), including its propensity
for homologous recombination. Strains can be broadly divided
into Clades 1, 2, and 3, as well as a clade phylogenetically
“intermediate” to Clades 2 and 3. The genomic diversity of
E. rhusiopathiae at smaller (e.g. national) scales has only begun
to be explored. However, studies conducted to date illustrate that
this may range from highly related clonal strains (e.g. as seen in
pigs in Japan; Ogawa et al., 2017), to phylogenetically diverse
strains, as observed in poultry in Germany (Janßen et al., 2015).
The degree of genomic diversity present could affect the ability
of vaccines to provide protection against the full spectrum of
circulating field strains.
An important component of E. rhusiopathiae diversity that
has remained relatively unstudied is that of its surface proteins.
Because of their high propensity for host-pathogen interactions,
surface proteins often play an important role in virulence
mechanisms, as well as in eliciting a host immune response,
thereby representing potential vaccine candidates (Gamberini
et al., 2005). One of the most critical immunogens for
E. rhusiopathiae identified to date is the surface protective antigen
(Spa)A protein (Makino et al., 1998; Imada et al., 1999; Shimoji
et al., 1999). Of the three different Spa types (A, B, and C)
that have been found in Erysipelothrix spp. (To and Nagai,
2007), SpaA is by far the most widely prevalent Spa type in
E. rhusiopathiae. In a global collection of E. rhusiopathiae isolates
examined from various host species, the spaA gene was found
in more than 90% of isolates (79/86), including all those from
pigs and poultry (Forde T. et al., 2016). This corroborates several
international studies where the spaA gene was the exclusive Spa
type found, including from pig outbreaks in Japan (n = 83) (To
et al., 2012), isolates from pigs in Australia (n = 44) (Eamens et al.,
2006), and a large study of 165 predominantly poultry isolates
from Germany (Janßen et al., 2015). It has been shown that the
N-terminal immunoprotective domain of this surface protein –
also referred to as the hypervariable domain – is the component
responsible for eliciting protective immunity (Figure 1; Imada
et al., 1999; Shimoji et al., 1999). SpaA also plays an important
role in pathogenesis by increasing resistance to phagocytosis
and promoting endothelial adherence (Harada et al., 2014;
Borrathybay et al., 2015; Zhu et al., 2017a,b). Several variants
(groups) of the SpaA protein have already been described, based
on amino acid differences within the immunoprotective domain
(Uchiyama et al., 2014; Janßen et al., 2015; Ogawa et al., 2017).
While tests have been conducted on both mice and pigs to
assess cross-protection among different Spa types using strains
representing multiple serotypes (To et al., 2010), it remains
unclear whether amino acid variants within the SpaA protein can
result in differences in protection. Moreover, the genetic sequence
of spaA of E. rhusiopathiae strains used in vaccines has not yet
been characterized.
Additional surface proteins that have a demonstrated role
in immunogenicity of E. rhusiopathiae include rhusiopathiae
surface protein A (RspA) (Shimoji et al., 2003), choline binding
protein B (cbpB) (Shi et al., 2013; Zhu et al., 2018) and
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Zhu
et al., 2018); these proteins have all elicited protection during
challenge studies in mice, and the latter two also in pigs. An
additional eight putative surface proteins were recently found
to give rise to varying degrees of protective immunity in mice
(Hu et al., 2017; Table 1). As with SpaA variants, the exact role
and the extant diversity of these different surface proteins among
E. rhusiopathiae strains have yet to be determined.
The objectives of this study were to (1) characterize the overall
genomic diversity of E. rhusiopathiae in British pigs and assess
the amount of genetic divergence between field strains and a
commonly used vaccine strain in the United Kingdom (UK), and
(2) to quantify the amount of genetic diversity in Spa and other
immunogenic surface proteins.
MATERIALS AND METHODS
Bacterial Isolates and Vaccine Strain
Archived E. rhusiopathiae isolates from clinical pig
erysipelas cases from across England and Wales were
provided by the UK Animal and Plant Health Agency
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FIGURE 1 | Schematic representation of the SpaA protein sequence. Based on To and Nagai, 2007. Numbers below indicate amino acid (AA) positions. Numbers
within the blue boxes represent the typical number of repeat units. The signal sequence (AA 1-29) is thought to be associated with the secretion mechanism for this
protein. The immunoprotective domain (AA 30-413) is the component conferring immunogenicity, and upon which typing schemes for SpaA have been developed.
The role of the proline-rich region (415–447) has not been well described. Seven to 13 repeats of a 20-AA sequence containing a GW module make up the
C-terminal domain of SpaA; these have a role in binding the SpaA protein to the bacterial cell surface.
TABLE 1 | Surface proteins of Erysipelothrix rhusiopathiae with a suspected role in immunogenicity.
Locus tag Nucleotide Amino acid
Gene Name/Description (former) Positionsa length length References
1 spaAb Choline-binding protein ERH_RS00500
(ERH_0094)
112,931–114,811 1881 626 Imada et al., 1999;
Shimoji et al., 1999
2 rspA Rhusiopathiae surface protein A;
B-type domain-containing protein;
LPXTG-motif cell wall anchor
ERH_RS03410
(ERH_0668)
701,546–707,524 5979 1992 Shimoji et al., 2003
3 CbpB Choline-binding protein ERH_RS03905
(ERH_0768)
813,020– 814,840 1821 606 Shi et al., 2013;
Zhu et al., 2018
4 GAPDH (gapA) type I glyceraldehyde-3-phosphate
dehydrogenase
ERH_RS07885
(ERH_1534)
1,618,401–1,619,405 (rev) 1005 334 Shi et al., 2013;
Zhu et al., 2018
5 Da (dap2) Dipeptidyl aminopeptidase; S9
family peptidase
ERH_RS00295
(ERH_0059)
62355–64328 (rev) 1974 657 Hu et al., 2017
6 CbpA Collagen-binding protein; cell wall
anchor
ERH_RS00405
(ERH_0075)
89263–94584 5322 1773 Hu et al., 2017
7 Plp Pectin lyase fold-containing protein ERH_RS00860
(ERH_0165)
196,260–200,819 4560 1519 Hu et al., 2017
8 Atsp ABC transporter, extracellular
solute-binding protein
ERH_RS01215
(ERH_0228)
262,816–264,261 1446 481 Hu et al., 2017
9 Neu (nanH) Neuraminidase; LPXTG-motif cell
wall anchor domain protein
ERH_RS01540
(ERH_0299)
331,513–335,127 (rev) 3615 1204 Hu et al., 2017
10 Bga Beta-galactosidase; DUF4982
domain-containing protein
ERH_RS03965
(ERH_0780)
825,779–832,054 6276 2091 Hu et al., 2017
11 Bml Basic membrane lipoprotein; BMP
family ABC transporter
substrate-binding protein
ERH_RS05080
(ERH_1005)
1,061,289–1,062,380 (rev) 1092 363 Hu et al., 2017
12 CwpA LPXTG-motif cell wall anchor
domain protein
ERH_RS07320
(ERH_1428)
1,500,578–1,506,982 (rev) 6405 2134 Hu et al., 2017
13 CwpB LPXTG-motif cell wall anchor
domain protein
ERH_RS07450
(ERH_1454)
1,537,616–1,540,657 (rev) 3042 1013 Hu et al., 2017
All listed proteins have experimentally been shown to be involved in eliciting a host immune response. aPositions are in relationship with reference strain Fujisawa
(NC_015601). bspaB and spaC sequences, with a role in immunogenicity of Erysipelothrix spp., were not found in any of the isolates in this study.
(APHA; Supplementary Table S1). A total of 48 isolates
were initially selected to uniformly represent as a wide a time
frame as possible; dates of isolation ranged from 1987 to
2014. Isolates were also selected for geographic representation,
including isolates submitted to 10 different regional Veterinary
Investigation Centers (Supplementary File S1, Supplementary
Figure S1). To minimize the inclusion of epidemiologically
linked isolates (i.e. stemming from a common outbreak), efforts
were made to select isolates from different years when originating
from the same investigation center. Isolates were serotyped prior
to this study using previously described methods (Opriessnig
et al., 2013); those selected for inclusion in this study aimed to
represent a mix of serotypes 1a, 1b and 2, which encompass
90% of the isolates recovered from clinical erysipelas in British
pigs (McNeil et al., 2017). DNA was extracted from isolates
regrown on blood agar plates using the DNeasy Blood & Tissue
kit (Qiagen). With the same kit, DNA was also extracted directly
from one of the most commonly used inactivated E. rhusiopathiae
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vaccines in the UK (referred to hereafter as the vaccine strain;
see Commercial Products Used). We also endeavored to perform
DNA extraction from a second commercial vaccine, however,
this vaccine did not test positive by E. rhusiopathiae probe-based
qPCR, and DNA of sufficient quantity (as measured by Qubit)
could not be extracted despite multiple attempts.
Library Preparation, Sequencing and
Assembly
Library preparation, sequencing and de novo assembly were
performed by MicrobesNG (Birmingham, UK). Libraries were
prepared using the Nextera XT v2 kit and sequenced on the
Illumina HiSeq2500 platform, generating 250 base pair paired-
end reads. Reads were trimmed using Trimmomatic (Bolger et al.,
2014), and assembled de novo using SPAdes v. 3.7.0 (Bankevich
et al., 2012) with default settings. Assembly quality metrics (i.e.
number of contigs, N50) were obtained using QUAST (Gurevich
et al., 2013). Three of the isolates submitted had poor sequencing
quality indicative of contamination (i.e. unexpected total length
and GC content) and were excluded from further analyses,
resulting in 45 whole genome E. rhusiopathiae sequences (WGS)
from British pigs. Since key questions in this study were related
to surface antigens and their relationship with a current vaccine
strain, the vaccine extract was submitted for sequencing twice on
two independent runs for variant confirmation.
Population Structure
To place the newly sequenced isolates (i.e. the vaccine strain and
the 45 British pig isolates from which high quality sequence data
were obtained) within the broader global population structure of
E. rhusiopathiae, a phylogenetic tree was estimated that included
an additional 75 isolates from Clades 2, 3 and the intermediate
clade (Forde T. et al., 2016) (Supplementary Table S1). The
Fujisawa reference genome (NC_015601.1), the first complete
high-quality genome for E. rhusiopathiae (Ogawa et al., 2011),
was also included; this is a virulent serotype 1a strain isolated
from a pig in Japan prior to 1985. Serotype was already known
for 10/75 of the global isolates. In silico serotype testing was
also done to detect isolates of serotypes 1a, 1b, 2, and 5. In
brief, BLAST searches of all de novo assemblies were done
using primer pairs described for each serotype (Shiraiwa et al.,
2018). A BLAST search was considered positive for a given
serotype if there were matches for both forward and reverse
primers across their full length with a maximum of one SNP
difference, and that yielded the expected amplicon length (i.e.
distance between primers). The phylogeny – based on core single
nucleotide polymorphisms (SNPs) – was built using Nullarbor1
(Seemann et al.) implemented through the CLIMB computing
platform for microbial genomics (Connor et al., 2016). The
Nullarbor pipeline uses the program Freebayes v1.1.0 for variant
calling across all isolates with respect to a reference genome. It
subsequently builds a core SNP alignment using Snippy v3.2,
where “core sites” are genomic positions that are present in all
the included isolates. This core alignment comprised 3490 SNPs.
FastTree v2.1.10 was then called within Nullarbor to infer the
1https://github.com/tseemann/nullarbor
phylogeny using maximum-likelihood based on the GTR + G4
model of substitution.
Variability of Spa and Other Surface
Protein Sequences
Spa genes were searched for in all newly sequenced isolates
by performing BLASTn searches using a custom database of
spaA, spaB, and spaC nucleotide sequences from different
serotypes available on GenBank (Supplementary Tables S1, S2),
implemented within Geneious v. 11.0.5 (Kearse et al., 2012).
A BLAST hit was considered positive for a particular Spa
type if it had greater than 95% pairwise identity; in practice,
homologous Spa types had ∼98% pairwise identity, while
heterologous types generally had ∼90% identity or lower.
Nucleotide sequences of the spaA gene based on the BLAST
hits were extracted from all de novo assemblies (n = 121). spaA
sequences were similarly extracted from seven whole genome
sequences of E. rhusiopathiae available on GenBank: Fujisawa,
SY1027 (NC_021354.1), GXBY-1 (NZ_CP014861.1), WH13013
(NZ_CP017116.1), NCTC7999 (NZ_UFYF01000001.1),
NCTC8163 (NZ_LR134439.1), and ML101 (NZ_CP029804.1).
Finally, to further explore the variability of this surface protein,
an additional 215 publicly available spaA nucleotide sequences
were downloaded (Supplementary Table S2), resulting in a
total of 343 spaA sequences. Translations were performed either
using the transeq program from EMBOSS (Rice et al., 2000), or
within Geneious, using translation Table 11 for bacteria. Amino
acid sequences were aligned using MUSCLE (Edgar, 2004),
implemented within Geneious, and any amino acid variants were
recorded in comparison with the Fujisawa reference sequence.
A phylogenetic tree was estimated from the protein alignment
using a Neighbor-Joining method implemented in Geneious
Tree Builder, using the Jukes-Cantor model.
The amino acid variability within 12 additional surface
proteins that have been shown to play a role in E. rhusiopathiae
immunogenicity was also examined (Table 1). A custom BLAST
database of the nucleotide sequences of these genes was created
based on the sequences from the Fujisawa reference genome
within the program Geneious. Each de novo assembly from
British pig isolates and the vaccine strain was queried to
identify and extract the homologous gene sequences, which
were then translated to amino acid sequences and aligned
within Geneious along with the Fujisawa reference sequence.
Phylogenies for each protein were estimated as described for
SpaA. Variants of these different surface proteins were identified
based on clustering observed in mid-point rooted phylogenies
(Supplementary File S2).
Conformation of SpaA Protein Variants
To assess the potential structural impact of SpaA protein variants
identified, the 3-D protein structure of a typical group 1 SpaA
(Figure 4) was initially modeled using the I-TASSER platform
(Roy et al., 2010). I-TASSER uses LOMETS, a meta-threading
server that combines several threading programs to detect
structural templates from the Protein Data Bank (PDB) using
threading or fold recognition. The threading-aligned regions
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of these templates provide the building blocks and spatial
restraints for the prediction of the target protein, with unaligned
areas predicted ab initio. Full-length structural models were
predicted by I-TASSER, and the best structural model – identified
through comparison of C-scores – was used for further analysis.
C-scores are typically bounded between −5 and 2 with higher
values indicating greater confidence in the predicted model
and −1.5 acting as a useful threshold above which more than
90% of predictions are correct (Roy et al., 2010). To assess the
structural similarity of the SpaA structural model to existing PDB
structures, template modeling score (TM-score) and root-mean-
square deviation (RMSD) were calculated across aligned Cα
atoms using TM-align v20170708 (Zhang and Skolnick, 2005).
TM-scores are bounded between 0 and 1 where 1 indicates
perfect structural alignment, scores above 0.5 assume roughly
the same fold while scores below 0.2 correspond to randomly
chosen unrelated proteins (Zhang and Skolnick, 2005). Mutations
were introduced using the PyMOL molecular graphics system
(Schrödinger2), where the most common rotamer was selected
and energy minimization was performed in the locality of
the mutated site.
Epitope scores were predicted per-residue based on amino
acid identity, surface exposure and side chain orientation using
BEpro (Sweredoski and Baldi, 2008). Amino acid diversity was
calculated using an alignment of all available E. rhusiopathiae
SpaA protein sequences (n = 343) (including residues 1–447 of
the N-terminal region). Diversity at each amino acid position was
calculated as the true diversity at q = 2 (Inverse Simpson index),
whereby 1 indicates a fully conserved position and numbers
greater than 1 indicate increasing diversity. Amino acid diversity
was visualized on the structural model using PyMOL.
RESULTS
Sequencing, Population Structure and
Serotype
Among the 45 newly sequenced E. rhusiopathiae isolates from
British pigs and the vaccine strain, a minimum mean sequencing
depth of 26X was achieved, with a mean of 82X. The majority
of the newly sequenced strains from British pigs fell within
Clade 2 (32/45 = 71.1%), as did the vaccine strain (Figure 2).
Five isolates (11.1%) were in Clade 3, while the remaining
17.8% (8/45) were within the intermediate clade. None of the
isolates belonged to Clade 1. The average number of core SNP
differences separating the pig isolates from one-another was
435 (median = 377, range 0–767). This was comparable to the
number of core SNPs separating the vaccine strain from the
field strains (median = 413, range 328–655). The core SNP
profile of the vaccine strain was 100% identical across the two
sequencing rounds. No clear geographic clustering was evident
based on submitting veterinary center. Similarly, no obvious
temporal clustering was apparent, indicating that rather than
strain turnover, multiple divergent strains have remained in
circulation throughout the study period (Figure 2). The genetic
2https://pymol.org
distance (based on core SNPs) of the British pig isolates from
the vaccine strain did not change appreciably over time, thus
providing no evidence for potential vaccine-induced selection
(Supplementary File S1, Supplementary Figure S2). The
phenotypically determined serotypes for the British pig isolates
and vaccine were confirmed in silico in 40 of 46 isolates, with
six discrepancies (Supplementary Table S1). However, upon re-
testing, the phenotypic serotype of these isolates matched that
predicted by in silico testing. Among the global collection, the
Fujisawa reference strain was confirmed as serotype 1a in silico,
while 19 isolates were designated as serotype 1b, 27 as serotype 2,
17 as serotype 5, and 12 had no BLAST hits for any of the primer
pairs, suggestive of belonging to a serotype other than 1a, 1b, 2 or
5. This corroborated with the previously determined serotype for
eight isolates, including one serotype 9 for which none of these
primer pairs matched. Two mismatches between phenotypic
and in silico serotype were found: 1. Isolate HC-585, previously
classified as serotype 1a, did not have any primer pair matches;
2. Isolate Mew22, a serotype “N” (i.e. does not react with any of
the panel of antisera), was classified as a serotype 1b. The reverse
primer sequence for serotype 5 was found to consistently have
one SNP difference with all serotype 5 isolates. The distribution
of different serotypes within the phylogeny is shown in Figure 3,
where there was limited correlation with Clade.
Occurrence and Variability of Spa
Proteins
The spaA gene was present in all the newly sequenced isolates,
while spaB and spaC genes were not detected. In the translated
SpaA protein sequences, substantial diversity was found within
the immunoprotective or “hypervariable” domain, which spans
amino acids 30–413 (Figure 1). All SpaA amino acid sequences
(n = 343) were initially classified into the five SpaA groups
previously described (Janßen et al., 2015) (Supplementary
Table S3), which are based upon amino acid variants in
this domain. Beyond the previously reported positions, three
additional variable amino acid sites were present in at least five
isolates, and thus considered discriminatory. These were variants
at position 97 (N/I), position 109 (N/H), and position 139 (Q/K).
There were also several amino acid variants (n = 53) present in
fewer than five isolates (Supplementary Table S4). One isolate
(20767, from a wild bird) had a highly divergent SpaA protein,
with 19 unique amino acids. If these sites are not considered,
there were 34 variable sites, four of which had two different amino
acid variants (3 alleles).
The phylogenetic tree of the different SpaA protein variants
suggests that there are two main groups (Figure 4), and we
found that these groups are correlated with the overall population
structure of E. rhusiopathiae (Figures 3, 5). We therefore propose
a simplified nomenclature for SpaA groups, where Group 1
has amino acid variants at positions 55 (V/I), 70 (K/N), 178
(G/D), 195 (D/N) and 303 (G/E) in relation with the Fujisawa
reference, consistent with the previous scheme proposed by
Janßen et al. (2015). All other previously described groups
are minor variants of what we now refer to as Group 2.
These variants appear to arise multiple times throughout the
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FIGURE 2 | Diversity of Erysipelothrix rhusiopathiae in British pigs as shown within a global phylogenetic context. This maximum likelihood phylogeny is based on
core single nucleotide polymorphisms (SNPs) identified through the Nullarbor pipeline. British pig isolates (n = 45) are represented by blue circles at branch tips, while
the vaccine strain is represented by a red star. Branches with no symbol are isolates from a broad global collection (n = 75) from various host species and
geographic locations representing Clades 2, 3 and the intermediate clade. An isolate from Clade 1 was used to determine the appropriate rooting position (not
shown). The Fujisawa strain was used as the reference genome. Spatio-temporal diversity of the British pig isolates is illustrated by color bars to the outside of the
phylogeny, with the inner color representing the year range of isolation, and the outer color bar representing the veterinary center to which the isolate was submitted.
phylogeny (Supplementary File S1, Supplementary Figure S3);
this is suggestive of either parallel evolution (homoplasy)
or recombination. A detailed description of how this SpaA
classification relates to previously described groups is found in
Supplementary Table S3 and Supplementary File S3.
All isolates within the SpaA group 1 belonged to Clade 2 or
the intermediate clade. All Clade 2 isolates possessed SpaA group
1 except for a single British pig isolate (swine100, Figure 3).
Since the majority of the British pig isolates belonged to Clade
2, SpaA group 1 was the variant found in the majority of these
strains (82%; Supplementary Table S1). The vaccine strain was
a variant of Group 1, with an additional amino acid difference
at position 109 (N/H). This variant was also found in seven
other sequences from GenBank; however, none of the British pig
isolates investigated in this study shared this difference.
Predicted Structure of SpaA
We aimed to assess the potential functional implications of
variant residues detected within SpaA. However, given that
the structure of SpaA is unknown and its function poorly
understood, its structure was predicted as an exploratory exercise.
A full-length structural model was produced using I-TASSER,
a program that predicts structure using a combination of
threading to existing protein structures and ab initio modeling.
The majority of the highest ranked structural templates for
the SpaA protein detected by I-TASSER were surface-located
choline-binding proteins of Streptococcus pneumoniae, either
phosphorylcholine esterase (Pce) also known as choline-binding
protein E (CbpE) (PDB ID: 2BIB; Hermoso et al., 2005) or
choline-binding protein F (CbpF) (PDB IDs: 2V04, 2V05; Molina
et al., 2009). Other Firmicutes templates from Clostridium difficile
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FIGURE 3 | Relationship of SpaA group, serotype, and immunogenic surface proteins to phylogenetic population structure. This phylogenetic tree is based on core
single nucleotide polymorphisms (SNPs), and was estimated using the Nullarbor pipeline (same sequence data as in Figure 2). British pig isolates are represented by
blue circles at branch tips, while the vaccine strain is represented by a red star. SpaA group (1 or 2) is shown by the yellow/orange color strip. Serotype (1a, 1b, 2, 5)
as determined in silico is shown by the purple/green color strip. Those where phenotypic testing was not performed or where in silico test results differed are not
shown. Variants of 8 different immunogenic surface proteins are shown by the black/gray color strips for all British pig isolates. Those shown in black are those which
cluster most closely with the variant found in the vaccine strain; isolates in dark gray represent isolates with surface protein variants in outlier groups
(Supplementary Table S1, Supplementary File S1).
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FIGURE 4 | Discriminatory amino acid positions within the immunoprotective domain of the SpaA protein of Erysipelothrix rhusiopathiae. Amino acid (AA) variant
positions with respect to the Fujisawa reference sequence are listed in the top row, with the amino acid found in the reference sequence shown in the second row.
The phylogenetic tree shown to the left shows the relatedness among the SpaA sequence variants. Variants in each group are shown in blue boxes, with the AA
change indicated.
FIGURE 5 | Relationship of Spa type and SpaA group to the population structure of Erysipelothrix spp. This figure is adapted from Forde T. et al., 2016. The tree is
rooted to other genera of the family Erysipelotrichaceae. Spa type and SpaA group are indicated in red. SpaA group is based on discriminatory amino acid variants
(Figure 4). ∗spaA and spaB have been reported only once each in Erysipelothrix tonsillarum (Pomaranski et al., 2017).
and Leuconostoc mesenteroides were also identified. The highest-
ranked structural model predicted using I-TASSER had a C-score
of −1.30 indicating a good degree of confidence in the predicted
structure (Roy et al., 2010).
Comparison with solved PDB structures showed that the
structural model of E. rhusiopathiae SpaA most closely resembled
the Pce protein of S. pneumoniae (Hermoso et al., 2005) (TM-
score = 0.82, RMSD = 1.50 Å for 524 aligned Cα atoms, 17.6%
amino acid sequence identity in structurally aligned region). The
S. pneumoniae Pce comprises an N-terminal catalytic module
(300 residues) and a C-terminal tail (228 residues) responsible
for choline-binding (Hermoso et al., 2005). The hypervariable
domain of the SpaA structural model (residues 30–413) aligned
to the Pce catalytic module (TM-score = 0.75, RMSD = 1.88 Å for
303 aligned Cα atoms), while the C-terminal domain (residues
448–626) aligned to the Pce choline-binding domain (TM-
score = 0.98, RMSD = 0.37 Å for 177 aligned Cα atoms).
While the function of the N-terminal domain is unknown,
we hypothesized that it might be similar to that of its closest
homolog, which we found to be the Pce protein of S. pneumoniae.
As such, we examined the proximity of variable SpaA positions
to the residues of the structural model homologous to those
comprising the Pce catalytic site. Residues of the S. pneumoniae
Pce protein catalytic domain active site were mapped to the SpaA
structural model using TM-align so that the proximity of variable
SpaA sites to the potential active site could be calculated. The
structural model of the E. rhusiopathiae SpaA protein is shown
in Figure 6, colored according to amino acid diversity calculated
across the alignment of available sequences. Of the residues with
the highest amino acid diversity (55, 70, 101, 178, 195, 203, 303,
426, and 435, Inverse Simpson index > 1.3), positions 70, 178
and 303 were closest to residues of the potential active site with
distances of under 10 Å (for comparison, the distance between
covalently bound residues was 3.5–4 Å). For position 109, the
position at which most E. rhusiopathiae sequences from British
pigs differ relative to the vaccine (Asn – His), the lowest distance
to a residue aligned to the Pce protein catalytic domain active site
was 13.3 Å which is beyond the range expected to be structurally
impacted by a mutation between His and Asn at that position.
The extent to which SpaA is recognized by antibodies of
the humoral immune system is not known. To investigate the
potential for variant residues to influence antibody recognition,
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FIGURE 6 | Structural model of Erysipelothrix rhusiopathiae SpaA protein
predicted using I-TASSER. Residues structurally aligned to the active site of
the S. pneumoniae Pce protein are colored magenta while the remaining
residues of the N-terminal domain (residues 1–447) are colored following the
legend according to amino acid diversity (Inverse Simpson index) calculated
from 343 SpaA sequences sourced from newly sequenced isolates and public
sequence databases. Residues of the C-terminal domain (residues 448–626)
are colored gray. (A) Cartoon representation of whole structural model
showing secondary structure. (B) Close up ribbon representation of
N-terminal domain with spheres highlighting the nine residues with highest
amino acid diversity (Inverse Simpson index > 1.3) and with residues
structurally aligned to the active site of the S. pneumoniae Pce protein
(magenta) shown in stick format. Figure created using Pymol (Schrödinger).
the degree to which their location within the structural model
showed epitope characteristics was assessed. Thus, to evaluate
the potential of the variant residues influencing recognition by
the humoral immune system, the structural model was used to
generate epitope scores that reflect the likelihood of each residue
belonging to a B-cell epitope. Epitope scores, which reflect the
likelihood of each residue belonging to a B-cell epitope, were
calculated for each residue within the SpaA structural model
based on surface exposure, amino acid identity and side chain
orientation (Sweredoski and Baldi, 2008). Of the nine high-
diversity positions, 55 and 435 were both placed among the
highest predicted epitope scores, at the 94th and 93rd percentile,
respectively, but there was no consistent relationship between
diversity and epitope scores. The epitope score associated with
position 109 on the SpaA was at only the 8th percentile calculated
across all positions, suggesting the position is unlikely to be
important for antibody recognition. For all positions, amino
acid diversity, predicted secondary structure, epitope score, and
aligned S. pneumoniae Pce protein active site residues are detailed
in Supplementary Table S6.
Occurrence and Variability of Other
Surface Proteins
Of the 12 other E. rhusiopathiae surface proteins examined, 11
were present in all isolates from British pigs and the vaccine
(i.e. were core genes). However, the degree to which amino
acid sequences were conserved varied greatly among proteins
(Table 2; Supplementary Table S5; Supplementary File S2). Of
the surface proteins examined, GAPDH was the most conserved,
with only a single variant across the 334 amino acid protein,
found in a single isolate (swine74). Atsp and Da were also highly
conserved, with 6 and 13 variant positions, respectively. It is
noteworthy that three of the six variant positions in Atsp were
unique to the vaccine strain. Of the 52 variant positions identified
in Bga, three of these were unique to the vaccine strain. One
isolate (swine98) also had a mutation conferring a premature stop
codon for this protein. A slightly higher proportion of sites varied
in Neu (3.4%), Bml (3.8%) and rspA (4.8%); the latter had four
sites unique to the vaccine. CbpA showed much higher diversity,
with variants at 162 of 1773 amino acid positions (9.1%), but none
of which were unique to the vaccine.
The only proteins with any insertions or deletions identified
among the British pig isolates were CbpB, Plp and CwpB. In
CbpB, one isolate (swine78) had a deletion of 20 amino acids,
corresponding to the loss of a repeat unit. In Plp, an insertion
of either 4 amino acids (16 strains) or 12 amino acids (two
strains) was present. In CwpB, a single isolate (swine103) had
a deletion of 4 amino acids (positions 971–974), while another
isolate (swine18) had an insertion of 7. This protein also had
the highest proportion of variant positions (27%), although the
majority of the variant sites (83%) were due to two isolates
whose sequences differed greatly from the others (swine18
and swine101; Supplementary Table S5 and Supplementary
File S2). Finally, one surface protein examined was variably
present among the isolates. Complete nucleotide sequences for
CwpA (5322 bp) were present in only 13 isolates, as well as in
an additional 6 isolates that were missing a stop codon. The
remaining 27 isolates had BLAST hits for this sequence ranging
from 758 – 3116 bp (median = 2610); the vaccine strain had a hit
length of 3116 bp. Some of the BLAST hits for the surface proteins
investigated were only partial sequences spread across multiple
contigs (i.e. had not been completely assembled) (Table 2). The
affected isolates had lower quality assemblies overall (swine94,
50, and 40), as shown by the lowest N50 values among the newly
sequenced isolates (Supplementary Table S1).
The phylogenetic trees generated for the different surface
proteins (Supplementary File S2) did not show concordance
with the core SNP phylogeny. This is illustrated in Figure 3,
where for each surface protein, the isolates that cluster most
closely with the protein sequence of the vaccine strain are shown.
There were no major changes to the distribution of the different
surface protein variants over the timeframe of the study period
(Supplementary File S1, Supplementary Figure S4).
DISCUSSION
Diversity of Circulating E. rhusiopathiae
Strains in Pigs in Great Britain and Their
Relation to a Commonly Used Vaccine
Strain
While the global genomic diversity of E. rhusiopathiae has been
characterized, how much of this genomic and functional diversity
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TABLE 2 | Amino acid (AA) sequence diversity in surface proteins related to immunogenicity of Erysipelothrix rhusiopathiae.
Protein BLAST hit results where coding
length # Variant AAs* # variant AAs Insertions/deletions and sequence was spread across
Surface protein (AAs) (% of total AAs) unique to vaccine premature stop codons multiple contigs+
rspA 1992 96 (4.8%) 4 swine40 (3 contigs) swine94 (3 contigs)
cbpB 606 27 (4.5%) 1 Deletion 20AAs swine78 (1 repeat
unit)
GAPDH (gapA) 334 1 (0.3%) 0
Dipeptidyl aminopeptidase
(Da, dap2)
657 13 (2%) 0
CbpA 1773 162 (9.1%) 0
Plp 1519–1531 91 (6%) 0 Insertion of either 4 AAs (16 strains)
or 12 AAs (2 strains)
swine40 (2 contigs)
Atsp 481 6 (1.2%) 3 swine50 (2 contigs)
Neuraminidase (Neu, nanH) 1204 41 (3.4%) 1
Beta-galactosidase (Bga) 2091 52 (2.6%) 3 swine98 stop codon at AA Pos 658 swine40 (3 contigs) swine50 (2 contigs)
swine94 (3 contigs)
Bml 364 14 (3.8%) 0 swine40 (2 contigs)
CwpA 2134 N/A N/A Full length BLAST hits in 13 isolates
(5322 bp) Missing stop codon in 6
isolates Remaining 27 isolates with
BLAST hits ranging from 758 – 3116 bp
(median = 2610)
CwpB 1009–1020 276 (27%) 1 Insertion 7AAs swine18 Deletion
4AAs swine103
swine40 (2 contigs)
Isolates were examined from British pigs (n = 45) and a commercially available vaccine strain in comparison with the Fujisawa reference strain. *Comparisons are made in
relationship with reference strain Fujisawa (NC_015601). +Complete coding sequences were found in all isolates (based on BLASTn searches of the de novo assembled
nucleotide sequences) unless otherwise stated. bp = base pairs.
is maintained at smaller scales was unclear. This study provides
a valuable contribution to our understanding of E. rhusiopathiae
genomics, and in particular provides novel data on the diversity
of surface antigens. Moreover, fully sequencing a commercial
vaccine strain of E. rhusiopathiae has provided valuable insights
into its relationship to circulating field strains.
Throughout the 27-year time period from which samples
were collected for this study (1987 – 2014), phylogenetically
diverse strains of E. rhusiopathiae were isolated from British pigs
(Figure 2). Similarly high diversity was previously observed in
poultry isolates from Germany based on multi-locus sequence
typing (Janßen et al., 2015), while the diversity of E. rhusiopathiae
circulating in pigs in Asia has been shown to be restricted to
strains within the intermediate clade (Ogawa et al., 2017). The
lower diversity of E. rhusiopathiae in Asian countries could
be due a more recent introduction of the pathogen, and/or
differences in animal trade, pig breeding, herd management
or biosecurity. The majority of the British pig isolates belong
to Clade 2, which differs from what was previously found in
North America, where all pig and poultry isolates investigated
(n = 14) belonged to Clade 3 (Forde T. et al., 2016), suggesting
different E. rhusiopathiae clades have become dominant on these
continents. The vaccine strain also belonged to Clade 2. We found
no evidence that E. rhusiopathiae strains in circulation in Great
Britain have diverged from the vaccine strain over the study
period. It would have been interesting to investigate the strains
associated with other commercially available vaccines, however,
we were unable to detect and extract E. rhusiopathiae DNA from
the second vaccine tested. Whether there is a component of
the vaccine adjuvant (e.g. aluminum hydroxide) that inhibited
detection of DNA by Qubit and PCR is unknown. None of the
isolates we sequenced from British pigs in this study belonged
to E. rhusiopathiae Clade 1, emphasizing the rarity of strains
from this clade causing disease in the major production species
worldwide; in a global collection of isolates previously sequenced
(Forde T. et al., 2016), only 8% (7/86) belonged to Clade 1, and
none of these were from pigs or poultry.
Spa Type and Correlation With
Population Structure and Clinical
Disease
No spaB or spaC genes were found among the E. rhusiopathiae
isolates from British pigs. Given the lack of Clade 1 isolates, this
finding was expected and is consistent with previous observations
that Clade 1 isolates carry the spaB gene, whereas Clade 2,
3 and intermediate isolates carry the spaA gene (Figure 5;
Forde T. et al., 2016). To date, spaC has only been associated
with Erysipelothrix sp. strain 2, and not E. rhusiopathiae. The
predominance of the spaA gene in isolates associated with clinical
erysipelas has been supported in several studies (Eamens et al.,
2006; To et al., 2012; Janßen et al., 2015). It therefore seems
that spaB and spaC (i.e. isolates belonging to E. rhusiopathiae
Clade 1 and E. sp. Strain 2) are less relevant when considering
vaccine design for production species. However, given that
E. rhusiopathiae Clade 1 is more commonly isolated from marine
mammals in captivity (Opriessnig et al., 2013; Forde T. et al.,
2016), and Erysipelothrix spp. carrying the spaC gene has recently
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been associated with disease in fish (Pomaranski et al., 2017),
protecting against Erysipelothrix spp. carrying these Spa types
could be of greater relevance for aquatic species. It was previously
suggested that Spa proteins are likely important virulence factors
associated with the pathogenic potential of E. rhusiopathiae in
comparison to the less pathogenic E. tonsillarum (To and Nagai,
2007), and until recently, no Spa-related genes or proteins had
been found in E. tonsillarum (To and Nagai, 2007; Shen et al.,
2010). To our knowledge, the occurrence of spaA and spaB genes
in E. tonsillarum has only been documented in one paper, among
isolates from ornamental fish (Pomaranski et al., 2017). However,
given that the species was defined based only on sequencing
of the gyrB gene, it is conceivable that this isolate may have
been misclassified.
SpaA Diversity, Correlation With
Population Structure, and Relevance for
Vaccination and Pathogenicity
This study represents the largest examination of the diversity
of SpaA protein sequences in E. rhusiopathiae conducted to
date, based on a collection of publicly available sequences and
de novo whole genome sequence assemblies (n = 343). With
this extensive collection of sequences, we were able to identify
additional amino acid variants that could further discriminate
SpaA protein sequences in comparison to previous typing
schemes (Uchiyama et al., 2014; Janßen et al., 2015). We were
also able to assess for correlation of these groups with population
structure (Figure 5). SpaA group 1 was only present in Clade
2 and the intermediate clade, but was absent from the Clade
3 isolates examined (Figure 3). Janßen et al. (2015) found a
strong correlation between SpaA group 1 and their ST complex
9. It is very likely that ST-9 corresponds with Clade 2, since
we found that all Clade 2 isolates had this SpaA variant with
one exception. We propose amalgamating all other previously
described SpaA groups into a single group, forthwith referred
to as SpaA group 2, since variants within this group are limited
to only one or two amino acid differences. Moreover, these
variants appear to be unconstrained by the core phylogeny
(Supplementary File S1). Such incongruent patterns could arise
either through parallel evolution (homoplasy), or, more likely,
through horizontal gene transfer, given the apparent propensity
for recombination observed in this species.
Whether the observed differences within the SpaA protein
could be responsible for differential immune protection – or
for differences in virulence – remains an important area for
future study. For instance, the vaccine strain tested in this study
belonged to Group 1 SpaA along with the majority of British pig
isolates, but had an amino acid change from N→H at position
109. Whether this could result in differential immune response is
unknown; however, based on the predicted structure of SpaA, we
found that this position is unlikely to represent an epitope.
Isolates with methionine at position 203 (i.e. Janßen Group
5, Uchiyama Group 1) were rare among the isolates examined
in this study. This variant was present in one British pig isolate
(Supplementary Tables S1, S3) and in three WGS available on
GenBank (GXBY-1, WH13013 and ML101), but in none of the
global collection of isolates (n = 75). It was previously found
in a handful of pig isolates from Germany (n = 4) (Janßen
et al., 2015). Otherwise, this variant has been mostly limited
to strains from China (Supplementary Table S2) and Japan,
where it is widespread and has been isolated from pigs with
acute, subacute and chronic infections (To et al., 2012; Uchiyama
et al., 2017) and where it appears to be increasing in prevalence
(Ogawa et al., 2017). There is, however, not yet any evidence of
this variant being associated with an increase in virulence (Zou
et al., 2015). One particular variant that would be worthy of
further investigation is that of alanine at position 195 (previously
classified as Group 3 by Uchiyama et al., 2014). This is the
variant carried by the pathogenic reference strain SY1027 from
China (Kwok et al., 2014), and was the variant carried by the
E. rhusiopathiae strain associated with large-scale muskox die-
offs in northern Canada (Kutz et al., 2015; Forde T.L. et al.,
2016). This variant has also been reported among pigs in Japan,
although is apparently being replaced by newer lineages (Ogawa
et al., 2017). Whether this amino acid change confers increased
virulence would be valuable to explore.
Predicted SpaA Protein Structure
We found that the amino acid sequence of the E. rhusiopathiae
SpaA protein predicts a protein structure most closely resembling
that of choline-binding proteins of Streptococcus pneumoniae.
Indeed, the homology in the C-terminal region of these
proteins had previously been described (Borrathybay et al.,
2015). This region – containing tandem repeats including
the GW motif – is a motif conserved across Gram-positive
bacteria that allows proteins to bind to choline residues
of techoic acid on the cell surface (Jedrzejas, 2001). It is
believed that this motif is what allows SpaA to bind to
phosphorylcholine of the of E. rhusiopathiae capsule (Harada
et al., 2014), facilitating binding to host endothelial cells.
To our knowledge, no studies have previously examined the
structure of the N-terminal region of SpaA, which is the
portion shown to be involved in its protective immunogenicity.
Among proteins for which the structure has been determined,
we found the N-terminal portion of the S. pneumoniae Pce
protein was the closest match, although with lower homology
in comparison with the C-terminal portion. S. pneumoniae
Pce modifies the distribution of phosphoryl choline on the
bacterial surface, impairing the ability of the host immune
system to efficiently bind, providing a mechanism for immune
escape (Hermoso et al., 2005). Given the predicted structural
similarity, it is possible that SpaA has a similar function, though
this hypothesis would need to be further explored through
functional assays.
Working with the hypothesis that SpaA may have a similar
function to S. pneumoniae Pce, we explored whether SpaA
positions with high amino diversity, including those differing
between groups 1 and 2, were located near to a possible active
site. The N-terminal module of the Pce protein contains a
binuclear Zn2 + catalytic center (Hermoso et al., 2005). Within
this active center, particular residues have been shown to be
involved in substrate binding and catalysis, facilitating teichoic
acid hydrolysis which releases phosphoryl choline moieties
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reducing recognition by the immune system. In SpaA, the variant
amino acid residues at positions 70, 178 and 303 were those
closest to potential active site, as based on homology with the
S. pneumoniae Pce protein. Since these are all variants that
distinguish between SpaA groups 1 and 2, it is possible that these
variants confer functional differences between these groups.
Alternatively, we considered that variable positions may have
played a role in recognition by the humoral immune system.
To do so, we assessed whether diverse amino acid sites tended
to occupy locations within the structural model that exhibited
signatures of epitope regions. With the notable exception of
position 55, a variant that differs between groups 1 and 2, and
position 435 that possessed very high predicted epitope scores,
the diverse positions did not show a general tendency toward high
epitope scores, suggesting pressure from the humoral immunity
may not be a major driver of the observed genetic diversity. The
role of SpaA in immune recognition has not been characterized in
great detail. In vitro experiments and challenge studies to assess
cross-protection, wherein isolates from different SpaA groups are
included, would be valuable.
Variability in Immunogenic Surface
Proteins
Our study provides novel information about the sequence
diversity of different immunogenic surface proteins of
E. rhusiopathiae. The degree of variability differed substantially
among the 12 proteins we investigated, ranging from proteins
that were nearly completely conserved across all 45 isolates
and the vaccine strain (GAPDH) to 27% of the amino acids
showing variation (CwpB), as well as some proteins with small
insertions and deletions (Plp and CwpB). Coding sequences for
these proteins were found to be core genes, with the exception
of CwpA which was variably present. Based on the phylogenetic
trees estimated for each protein (Supplementary File S1),
variants of the different proteins did not correlate with the
phylogenetic relationship among isolates (Figure 3), suggesting
that horizontal transfer of genes encoding for antigens is
commonplace for E. rhusiopathiae.
We investigated whether there was any evidence of
antigenic divergence (Bart et al., 2014) between field strains
of E. rhusiopathiae and a common vaccine strain, as this could
potentially be of concern for vaccine efficacy. However, we did
not observe any such temporal shift in surface protein variants
for any of the antigens we examined (Supplementary File S1).
The vaccine strain had unique amino acids in 5 of the 12 surface
proteins examined – rspA, Bga, Atsp, Neu and CwpB (i.e. that
were not present among the 45 pig isolates). Of particular
note is in Atsp, where this included three of only six variants
across the protein and among all isolates. The impact of these
differences – if any – would be valuable to explore. The most
conserved surface protein – GAPDH – has been confirmed to
be expressed at the cell surface (Shi et al., 2013), and like SpaA,
RspA and RspB, has a role in endothelial adhesion (Zhu et al.,
2017c). It was recently found to provide good protection in
both murine and porcine challenge models (Zhu et al., 2018).
These authors suggested that given its proven role as a protective
antigen, in addition to being a housekeeping gene and thus
highly conserved – as confirmed by this study – GAPDH could
make a good candidate for a subunit vaccine. Indeed, subunit
vaccines based on surface-exposed proteins have been proposed
as a potential alternative to traditional live or bacterin-based
vaccines (Hu et al., 2017).
Serotype as an Epidemiological and
Immunological Marker
E. rhusiopathiae isolates have historically been described by their
serotype, which is based on testing for agglutination of an isolate
against a panel of serotype-specific antisera using a double agar-
gel diffusion method (Kucsera, 1973). It was recently determined
that a chromosomal region encoding a putative pathway for
polysaccharide biosynthesis is responsible for defining the
antigenicity of the major serotypes 1a, 1b, 2 and 5, and that
these can be distinguished based on their genetic composition at
this locus (Ogawa et al., 2018; Shiraiwa et al., 2018). However,
this present study lends further support to the fact that serotype
is inappropriate for assessing the genetic relatedness among
isolates at larger scales (e.g. at a national level). It has even been
reported that the same serotypes can be found across multiple
Erysipelothrix species (Takahashi et al., 2008; McNeil et al., 2017).
Given the lack of phylogenetic informativeness of serotype, it
may not be the most relevant feature by which to primarily
classify isolates. Rather, a hierarchical approach should be taken
(i.e. Figure 5), wherein Erysipelothrix spp. isolates are described
by species, clade and/or Spa type, followed by SpaA group and
serotype. The value of serotype as an epidemiological marker
at smaller scales (e.g. within or between farm spread) would be
valuable to assess.
Whether serotype is a relevant trait for predicting cross-
protection among strains remains unknown and warrants further
study. It has been suggested that vaccines based on serotype
2 strains confer protection against serotype 1 and 2 strains in
pigs, as well as other serotypes to a variable degree (Wood
et al., 1981; Takahashi et al., 1984; Sawada and Takahashi, 1987;
Kitajima et al., 1998). Since serotypes 1 and 2 are those most
commonly associated with clinical disease globally (Wood and
Harrington, 1978; Cross and Claxton, 1979; Takahashi et al.,
1996; Opriessnig et al., 2004; Coutinho et al., 2011; McNeil et al.,
2017), these challenge studies suggest that currently available
vaccines should confer protective immunity against a variety of
strains. However, since these pig challenge studies have only
included one representative strain per serotype, the potential for
confounding is very high (i.e. the possibility that these findings
are based on immunogenic features other than serotype), making
it difficult to assess the likelihood or relevance of serotype-
associated cross protection.
The newly reported PCR scheme (Shiraiwa et al., 2018)
for distinguishing among serotypes 1a, 1b, 2 and 5 was
successfully applied in silico to determine the serotype of
sequenced isolates for which serotype was not previously known.
Initial discrepancies between phenotypic and in silico results
for some British pig isolates were resolved upon re-running
the agglutination tests on fresh subcultures, suggesting that the
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in silico method may produce more accurate and reproducible
results than standard methods. However, as the authors of
this PCR scheme previously noted and as we found for global
isolate MEW22, one limitation is that certain serovars that
would be phenotypically untypeable (“N”) using the double
agar-gel diffusion method may be assigned to a serotype. This
likely represents the original serotype that no longer yields
serotype-specific antigen due to only minor genetic differences
that result in changes in antigen-antibody reactions. Further
studies will be valuable to expand our understanding of the
genetic basis for other serotypes and the molecular tools
available for distinguishing them. We found that the reverse
primer sequence for serotype 5 had one nucleotide discrepancy
with all isolates of this serotype in the global collection
(n = 17); this sequence should therefore be updated to 5′-
GAAATAATGCCAATAGATGGAGCACC-3′.
Vaccine Cross Protection
Vaccination success is multifactorial, and includes factors related
to delivery (e.g. maintenance of cold chain), host-related factors
(e.g. age, health status, genetic factors), and factors related to
the pathogen. This study highlights important knowledge gaps
associated with pathogen-related factors for E. rhusiopathiae
vaccination, namely what are the determinants of protective
immunity, and what features confer cross-protection. Protection
induced by E. rhusiopathiae vaccination is via both cell-
mediated and humoral immunity (Shimoji, 2000; Pomorska-
Mól et al., 2012). Protective immunity is more difficult to
elucidate, as it can only be assessed by challenge studies. It
is likely stimulated via a complex array of antigens, including
proteins and polysaccharides. Ultimately, it would be valuable
for producers and clinicians to know what vaccine(s) would
be suitable to provide protection against the specific strains
found on a farm, but information to make such a judgment
is currently lacking. The surface proteins explored in this
study have all been shown to be immunogenic, but whether
differences in their structure or their presence or absence
can impact a strain’s ability to confer a protective immune
response against different strains remains unknown. In most
challenge studies that have been conducted in both mice and
pigs, the majority of E. rhusiopathiae vaccines have provided a
protective immune response against a range of different strains.
The key question for the field may therefore be ‘What genetic
and/or antigenic differences between strains would result in a
failure to provide cross protection?’. There is evidence that the
most common vaccine strains are not consistently protective
against strains assigned to serotypes 9 or 10 (Wood, 1979;
Wood et al., 1981; Takahashi et al., 1984), however, these
strains are likely sufficiently rare in field conditions to make
this a minor concern (Haesebrouck et al., 2004). It has been
well recognized that gram-positive bacterial cell wall antigens,
including lipoteichoic acid, have immunomodulating properties
(Shimoji et al., 2019). It is possible that serotype differences in
E. rhusiopathiae result in different immunostimulatory potencies
(i.e. have a role as adjuvants), but this requires further studies
for confirmation. Whether phylogenetic distance (e.g. differences
in clade) impacts the ability of a vaccine to confer protective
immunity is an important area of study that has yet to be
explored. For instance, it is not known whether the vaccine
strain (Clade 2) would be protective against more divergent
isolates from Clade 3. Similarly, the relevance of surface protein
variants – including SpaA groups – for immune cross-protection
is unknown. This could initially be explored using serum from
immunized pigs, and testing for antibody responses against
different strains through ELISA. A further complication is the
possibility of mixed infection, which we previously showed to
be quite common for E. rhusiopathiae infection, at least in wild
ungulates (Forde T.L. et al., 2016). If a host were infected with
multiple strains, particular variants might gain hold if they are
undetected by the immune system. The inclusion of multiple
strains in a single vaccine could potentially overcome some
of these issues.
CONCLUSION
In this study, we show that diverse E. rhusiopathiae strains have
been circulating in pigs in Great Britain over the past few decades,
and that the average genetic distance of these field strains from
the vaccine strain has remained relatively stable over time. This
study provides further support that SpaA is the most relevant Spa
type associated with clinical erysipelas in production species (i.e.
pigs and poultry); suggestions to update the nomenclature related
to SpaA groups based on amino acid variants are provided. We
provide novel data on the degree of conservation of various
immunogenic surface proteins, and demonstrate that horizontal
gene transfer has likely contributed to the observed diversity.
Research into which variables are relevant for conferring cross-
protection will be critical for understanding the relevance of this
diversity for vaccine development. As the agricultural industry
is working to reduce the use of antibiotics due to increasing
concerns related to antimicrobial resistance, the availability and
selection of effective vaccines is increasingly important. Variants
identified in this study could serve as a basis for guiding the
selection of strains to be included in future in vitro and in vivo
challenge studies.
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